EMA Adopts Trial Transparency Policy

Drug Industry Daily
A A
Manufacturers that sell drugs in the European Union will soon have to make publicly available clinical trial data supporting approval of those products, under a landmark transparency policy adopted yesterday by the European Medicines Agency.

To View This Article:

Login

Subscribe To Drug Industry Daily